Literature DB >> 15260988

Heritable integration of kDNA minicircle sequences from Trypanosoma cruzi into the avian genome: insights into human Chagas disease.

Nadjar Nitz1, Clever Gomes, Ana de Cássia Rosa, Marian R D'Souza-Ault, Francisco Moreno, Liana Lauria-Pires, Rubens J Nascimento, Antonio R L Teixeira.   

Abstract

We demonstrate the genetic transfer of DNA between eukaryotes from different kingdoms. The mitochondrial kinetoplast DNA (kDNA) of the intracellular parasite Trypanosoma cruzi is transferred to human patients with Chagas disease. This transfer was reproduced experimentally in rabbits and chickens. The kDNA is integrated into the host genome. In the human chromosomes, five loci were identified as integration sites, and the beta-globin locus and LINE-1 retrotransposons were frequently targeted. Short repeated sequences in the parasite and the target host DNAs favor kDNA integration by homologous recombination. Introduced kDNA was present in offspring of chronically infected rabbits and in chickens hatched from T. cruzi-inoculated eggs. kDNA incorporated into the chicken germline was inherited through the F2 generation in the absence of persistent infection. kDNA integration represents a potential cause for the autoimmune response that develops in a percentage of chronic Chagas patients, which can now be approached experimentally.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15260988     DOI: 10.1016/j.cell.2004.07.001

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  13 in total

Review 1.  Applying horizontal gene transfer phenomena to enhance non-viral gene therapy.

Authors:  Jacob J Elmer; Matthew D Christensen; Kaushal Rege
Journal:  J Control Release       Date:  2013-08-30       Impact factor: 9.776

Review 2.  Unexplained complexity of the mitochondrial genome and transcriptome in kinetoplastid flagellates.

Authors:  Julius Lukes; Hassan Hashimi; Alena Zíková
Journal:  Curr Genet       Date:  2005-11-04       Impact factor: 3.886

Review 3.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Two hybridization events define the population structure of Trypanosoma cruzi.

Authors:  Scott J Westenberger; Christian Barnabé; David A Campbell; Nancy R Sturm
Journal:  Genetics       Date:  2005-07-05       Impact factor: 4.562

Review 5.  Chagas disease.

Authors:  A R L Teixeira; N Nitz; M C Guimaro; C Gomes; C A Santos-Buch
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

Review 6.  Cell competition in development, homeostasis and cancer.

Authors:  Sanne M van Neerven; Louis Vermeulen
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-29       Impact factor: 113.915

7.  Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi.

Authors:  H R Martins; R Moreira Silva; H M S Valadares; M J O Toledo; V M Veloso; D M Vitelli-Avelar; C M Carneiro; G L L Machado-Coelho; M T Bahia; O A Martins-Filho; A M Macedo; M Lana
Journal:  Antimicrob Agents Chemother       Date:  2007-07-16       Impact factor: 5.191

8.  Pathogenesis of Chagas disease: time to move on.

Authors:  Fabiana S Machado; Kevin M Tyler; Fatima Brant; Lisia Esper; Mauro M Teixeira; Herbert B Tanowitz
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

9.  Parasite induced genetically driven autoimmune Chagas heart disease in the chicken model.

Authors:  Antonio R L Teixeira; Nadjar Nitz; Francisco M Bernal; Mariana M Hecht
Journal:  J Vis Exp       Date:  2012-07-29       Impact factor: 1.355

Review 10.  What is the future of peer review? Why is there fraud in science? Is plagiarism out of control? Why do scientists do bad things? Is it all a case of: "all that is necessary for the triumph of evil is that good men do nothing"?

Authors:  Chris R Triggle; David J Triggle
Journal:  Vasc Health Risk Manag       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.